![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 9, 6949-6959, March 1, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
, andFrom the Biology Department, Woods Hole Oceanographic Institution, Woods Hole, Massachusetts 02543
Received for publication, November 9, 2001, and in revised form, December 3, 2001
| |
ABSTRACT |
|---|
|
|
|---|
The effects of
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related
compounds occur via the aryl hydrocarbon receptor (AHR), a member of
the basic helix-loop-helix-Per-ARNT-Sim homology (bHLH-PAS) protein
superfamily. A single AHR gene has been identified in mammals, whereas many fish species, including the Atlantic killifish (Fundulus heteroclitus) possess two distinct
AHR genes (AHR1 and a novel form,
AHR2). A mouse bHLH-PAS protein closely related to AHR and
designated AHR repressor (AHRR) is induced by 3-methylcholanthrene and
represses the transcriptional activity of the AHR. To determine whether
AHRR is the mammalian ortholog of fish AHR2 and to investigate the
mechanisms by which AHRR regulates AHR function, we cloned an AHRR
ortholog in F. heteroclitus with high sequence identity to
the mouse and human AHRRs. Killifish AHRR encodes a 680-residue protein
with a predicted molecular mass of 75.2 kDa. We show that in
vitro expressed AHRR proteins from human, mouse, and killifish all fail to bind [3H]TCDD or
[3H] The AHR1 is a
ligand-activated transcription factor through which TCDD and other
polyhalogenated and polycyclic aromatic hydrocarbons cause altered gene
expression and toxicity (1-3). When activated by ligand binding, the
AHR forms a complex with ARNT that regulates the expression of target
genes by interacting with AHR response elements (AHREs; also known as
xenobiotic response elements or dioxin response
elements)2 (4). The AHR may
also possess physiological functions that are independent of exogenous
chemical exposure (5-7).
The AHR and ARNT belong to the bHLH-PAS superfamily of transcription
factors, members of which play key roles in development and
environmental sensing (8, 9). The vertebrate bHLH-PAS superfamily
consists of at least nine "paralog groups," each of which contains
two or three closely related genes (paralogs) that arose by
duplication from an ancestral invertebrate homolog (10, 11). Two
AHR genes3 have
been identified in vertebrate animals. The first AHR was originally
identified in mice (1, 12, 13) and is now known to be present also in
other vertebrates (14-16), including fish, where it is called AHR1
(10, 17, 18). A second, highly divergent AHR (AHR2) has been identified
in fish (10, 17, 19-21) but not yet in mammals. Recently, an
AHR-related gene designated AHR repressor (AHRR) was
identified in mice (22) and humans (23, 24). The mouse AHRR (22) acts
as a negative regulator of AHR function by competing with AHR for the
available pool of ARNT and by forming AHRR-ARNT complexes that bind to
AHREs but are transcriptionally inactive (22). The expression of mouse
AHRR mRNA is inducible by 3MC via AHR-dependent
activation of AHREs in the AHRR gene promoter (22, 25).
A better understanding of the function and regulation of the AHR
signaling pathway requires a more complete characterization of the
diversity of positive and negative regulatory factors and the
interactions among them. The identification of AHRR in mice and humans
raised several questions concerning the evolutionary and functional
relationships between AHR1, AHR2, and AHRR. Are fish AHR2
and mammalian AHRR orthologous genes (i.e.
descended from a single ancestral gene in the last common ancestor of
fish and mammals) or do fish also possess an AHRR gene? Is
AHRR capable of repressing the function of both AHR1 and AHR2? Are both
AHR1 and AHR2 involved in the regulation of AHRR expression? Is AHRR capable of high affinity binding of TCDD and other aromatic compounds that are known ligands for AHR/AHR1 and AHR2 (1, 17)? Does enhanced
expression of AHRR occur in fish selected for genetic resistance to
TCDD?
To understand the relationship between mammalian AHRR and fish AHR2 and
to investigate the mechanisms by which (i) AHRR regulates AHR function
and (ii) AHRs regulate AHRR expression, we cloned and characterized an
AHRR homolog from the estuarine teleost Fundulus heteroclitus (mummichog or Atlantic killifish). F. heteroclitus is an early vertebrate model system for studying the
function, evolution, and adaptive significance of AHR signaling
pathways. We have characterized previously other killifish bHLH-PAS
proteins, including AHR1 and AHR2 (10, 17), ARNT2 (26), and HIF-2 Chemicals--
2,3,7,8-Tetrachloro[1,6-3H]dibenzo-p-dioxin
([3H]TCCD, 35 Ci/mmol, >99% radiochemical purity as
assessed by high pressure liquid chromatography (30)) and
[3H]BNF ([3',5'-3H] Fish Collection and RNA Isolation--
F.
heteroclitus were collected in salt marshes, Cape Cod, MA, or New
Bedford Harbor, MA, as described earlier (17, 28). The dissected organs
were immediately frozen in liquid nitrogen. Total RNA was isolated
using RNA STAT-60 (Tel-Test B, Inc., Friendswood, TX).
Poly(A)+ RNA was purified with oligo(dT) spin columns (5 Prime Oligonucleotide Primers--
Primers were synthesized by
Invitrogen or Integrated DNA Technologies, Inc. (Coralville, IA), and
were used as described. Primer sequences are as follows: Qf
5'-AACCCITCIAAGMGICAYMG-3'; RR8r 5'-AAYTTIARYTTICCYTGRAAYTGCAT-3'; RR1r
5'-TCATGGTCTTGCGCTCCGCGGAGGTAGC-3'; RR20r
5'-TTCTGGATGGGCTTCCTCCGCTTTCTGC-3'; RRkoz2
5'-GGGGTACCTGCTACCTCCGCGGAGCGCAAG-3'; RRterm2
5'-GCTCTAGACATGCGTGGGTAATGCTCTCTC-3';RRfwd
5'-TCCGCGTCAAAAGCTTCTTCCAAGCGAG-3'; RRrev
5'-TCACCAAGCTCCATCGGAGAGATAATCC-3'; actinF
5'-CCATTGGCAACGAGAGGTTCCGTTGC-3'; actinR
5'-CTCATCGTACTCCTGCTTGCTGATCC-3'.
RT-PCR and 5'-/3'-RACE--
One µg of poly(A)+ RNA
from ovary or liver was reverse-transcribed with random hexamers using
the Gene-Amp RNA-PCR kit (PerkinElmer Life Sciences) following the
manufacturer's directions. The degenerate primers Qf and RR-8r and
TaqGold DNA polymerase (Applied Biosystems, Inc., Branchburg, NJ) were
used in the PCR. The amplification parameters are as follows: 94 °C,
10 min, 94 °C, 15 s/52 °C, 30 s (35 cycles); 72 °C, 10 min. Double-stranded cDNA from killifish ovary was synthesized
using a Marathon cDNA Amplification kit (CLONTECH, Palo Alto, CA). Adaptors were ligated to
both ends of the cDNAs. Gene-specific primers were coupled with
adaptor primers in the PCR using Advantage DNA polymerase mix
(CLONTECH). For 5'-RACE, primer RRr1 and nested
primer RRr2 were used. For 3'-RACE, primer RRf1 and nested primer
RRf2 were used. The touchdown PCR (31) parameters are as
follows: 94 °C, 1 min, 94 °C, 5 s/73 °C, 1.5 min for 5 cycles;
94 °C, 5 s/71 °C, 1.5 min for 5 cycles; 94 °C, 5 s/69 °C,
1.5 min for 25 cycles.
DNA Sequence and Phylogenetic Analysis--
All PCR products
were cloned into the pGEM-T Easy vector (Promega, Madison, WI) and
sequenced on an Applied Biosystems Inc. 373A Stretch DNA Sequencer
(University of Maine DNA Sequencing Facility, Orono, ME). DNA sequences
were assembled and translated using MacVector/AssemblyLign sequence
analysis software (Oxford Molecular Group, Madison, WI). Multiple
sequence alignments were performed using ClustalX (32). The aligned
amino acid sequences (corresponding to aa 1-414 of human AHR) of
killifish, mouse, and human AHRRs plus selected mammalian and fish AHRs
were used to construct phylogenetic trees using Maximum Parsimony and
Distance criteria in PAUP*4.0b8 (33), as described previously (10).
Genome Walking--
F. heteroclitus genomic DNA was
isolated from testes by homogenizing the tissue in 0.2% Triton X-100,
1 M NH4OH, followed by phenol/chloroform
extractions and ethanol precipitation (34). The protocol for
CLONTECH's Genome Walking kit was followed for cloning the promoter region of the AHRR. Briefly, 2.5 µg of genomic DNA was digested overnight with four blunt-cutting restriction enzymes.
The digests were extracted with phenol/chloroform and precipitated with
ethanol. Adaptors (Marathon cDNA Amplification kit,
CLONTECH) were ligated to the genomic DNA
fragments. PCR was performed on the adaptor-ligated fragments with
gene-specific primers (RR20r and nested primer RR1r) and adaptor
primers using the Advantage polymerase mix
(CLONTECH). The amplification parameters are as
follows: 94 °C, 2 s/72 °C, 4 min for 7 cycles and 94 °C, 2 s/67 °C, 4 min for 32 cycles, followed by 67 °C, 4-min final extension.
Expression Constructs--
Full-length AHR repressor cDNA
was amplified with the primers RRkoz2 and RRterm2 from the cDNA
prepared for the RACE procedure above. The clones were digested with
KpnI and XbaI at the primer sites and ligated
into the same sites in pcDNA 3.1/Zeo (+) vector (Invitrogen, Inc.,
Carlsbad, CA) to make pcDNA-FhAHRR. Several full-length clones were
sequenced to ensure accuracy of the sequence. The pGL-RR reporter
construct was made by inserting the 2358-bp AHRR promoter fragment into
pGL3-Basic vector (Promega) to direct expression of the luciferase
reporter gene. The mouse AHRR cDNA (plasmid pBSKmAhRR; a gift from
Y. Fujii-Kuriyama, Tohoku University, Japan) (22) was inserted into the
pcDNA 3.1 vector to allow for mammalian expression and renamed
pcDNA-mAHRR. The human AHRR cDNA (clone fH08618 of KIAA1234; a
gift from Dr. Takahiro Nagase, Kazusa DNA Research Institute, Chiba,
Japan) (23) was inserted into pcDNA 3.1 and renamed
pcDNA-hAHRR. Mouse AHR (pSportMAHR) (13) and human AHR
(pSporthAHR2) and ARNT (pSportARNT) (14, 35) expression vectors were
generously provided by Dr. C. Bradfield (University of Wisconsin,
Madison, WI). The plasmid pGudLuc 6.1, which is derived from pGudLuc1.1
(36) and contains the firefly luciferase reporter gene under the
control of an MMTV promoter regulated by four AHREs from the murine
Cyp1A1 promoter (37), was a generous gift from Dr. M. Denison (University of California, Davis). The killifish AHR2
expression plasmid pcDNA-FhAHR2 was prepared by subcloning the
insert from pDPFhAHR2 (17) into pcDNA. The killifish AHR1
expression plasmid pcDNA-FhAHR1*1 represents the predominant AHR1
allele; it is highly similar to the sequence of the pSPFhAHR1 construct
reported earlier (17) except that the encoded protein differs at six
amino acids.4
In Vitro Protein Synthesis and Ligand-binding Assay--
TnT
Quick-coupled Reticulocyte Lysate Systems (Promega) were used to
synthesize [35S]methionine-labeled or unlabeled proteins
following manufacturer's directions. Five µl of the
[35S]methionine-labeled TnT reactions were subjected to
SDS-PAGE, followed by fluorography. AHR and AHRR ligand binding was
determined using unlabeled proteins by velocity sedimentation on
sucrose gradients in a vertical tube rotor as described previously (17) with the following modifications. The TnT reactions were incubated overnight at 4 °C with [3H]TCDD (8 nM) ± TCDF (800 nM) or with
[3H]BNF (10 nM) ± BNF (1 µM). Nonspecific binding was determined by reactions
containing an empty vector (unprogrammed lysate (UPL)) as described
previously (17, 38).
Cell Culture, Transfection, and Luciferase Assays--
COS-7
monkey kidney cells were purchased from ATCC (Manassas, VA) and
maintained in DMEM (Sigma) supplemented with fetal calf serum (10%
final concentration) (Sigma) at 37 °C under 5% CO2. Cells were plated at 4 × 104 cells/well in 48-well
plates. Transfections were carried out 24 h after plating in
triplicate wells. DNA and LipofectAMINE 2000 reagent (Invitrogen) were
each diluted in serum-free DMEM. For each well, a total of ~300 ng of
DNA was complexed with 1 µl of LipofectAMINE 2000. The mixture was
then added to cells in DMEM with serum. Cells were treated 5 h
after transfection with either Me2SO or TCDD (10 nM) at 0.5% final Me2SO concentration. Renilla luciferase (pRL-TK, Promega) was used as the
transfection control. The amounts of transfected killifish AHR1 and
AHR2 DNA were adjusted to optimize the fold inducibility of pGudLuc6.1 over basal reporter expression. Killifish AHR1, AHR2, ARNT2 and AHRR
expression constructs were in pcDNA3.1 driven by the CMV promoter.
Transfected DNA amounts were 5 ng of AHR1, 0.5 ng of AHR2, 50 ng of
ARNT2, 20 ng of pGudLuc 6.1, and 3 ng of pRL-TK, unless otherwise
indicated. The total amount of transfected DNA was kept constant by
addition of pcDNA vector with no insert. Cells were lysed 18 h
after dosing, and luminescence was measured using the Dual Luciferase
Assay kit (Promega) in a TD 20/20 Luminometer (Turner Designs,
Sunnyvale, CA). The final luminescence values are expressed as a ratio
of the firefly luciferase units to the Renilla luciferase units.
Tissue-specific Expression--
Total RNA was isolated from
several tissues of killifish treated with TCDD or a mixture of PCBs
(65% Aroclor 1254, 35% Aroclor 1242); expression of AHR1, AHR2, and
CYP1A in these samples has been reported previously (28). Total RNA (2 µg) was reverse-transcribed using the Omniscript cDNA synthesis
kit (Qiagen, Valencia, CA). The RRfwd/RRrev primer pair was used to
amplify a 735-bp fragment of the killifish AHRR, and a 349-bp actin
fragment was amplified in separate PCRs using actinF/actinR primers.
The primer pairs for AHRR were designed to overlap exon-exon junctions,
thereby avoiding amplification of any contaminating genomic DNA. The
linear range for the amplification was determined by varying the number of cycles from 20 to 35 with 3-cycle increments and using 2, 4, 6, and
8 µl of template cDNA in a 100-µl reaction (data not shown). Final reaction conditions included 4 µl of template cDNA in each reaction with AmpliTaq Gold DNA polymerase (PerkinElmer Life Sciences); the numbers of amplification cycles chosen in the linear range for AHRR
and actin were 33 and 28 cycles, respectively. The cycling conditions
are as follows: 95 °C, 10 min, 95 °C, 15 s, 65 °C, 30 s for 33 or 28 cycles; 72 °C, 7 min. Under these conditions, the amount of PCR products amplified from gonad cDNA was linearly related to cycle number and amount of template. Ten-µl aliquots from
each reaction were run on 1.5% agarose gels, followed by ethidium
bromide staining. Band intensities were quantified using a ChemImager
4000 low light imaging system (Alpha Innotech, San Leandro, CA) with
automatic background subtraction.
Identification of a F. heteroclitus AHRR cDNA--
Previously,
we identified two highly divergent AHR homologs (AHR1 and AHR2) in
F. heteroclitus (17). In light of the recent characterization of a mammalian AHR-related bHLH-PAS protein, AHRR
(22), we sought to determine the relationship between mammalian AHRR
and fish AHR2 by investigating the presence of an AHRR homolog in
killifish and characterizing its interactions with AHR1 and AHR2.
Degenerate PCR primers, designed to recognize regions that are
conserved among mouse and human AHRR proteins but divergent from AHRs,
were used in RT-PCR. The primer pair Qf/RR-8r amplified a 670-bp
cDNA from killifish ovary. The deduced amino acid sequence of this
fragment shared 63% identity with the corresponding region of the
mouse AHRR but was distinct from killifish AHR1 (47% amino acid
identity) and AHR2 (48% identity). The complete coding sequence for
this cDNA, including 330 bp of 5'UTR and 50 bp of 3'UTR, was obtained by RACE (Fig. 1); sequence
analysis confirmed its identity as an ortholog of the mouse AHRR (see
below). The killifish AHRR cDNA encodes 680 amino acids with a
deduced molecular mass of 75.2 kDa. Sequence comparison of
killifish, mouse, and human AHRR proteins and killifish and mouse AHRs
revealed significant sequence identity in the N-terminal region,
including the bHLH and PAS-A domains, and a divergence of AHRR
sequences from AHRs in the PAS-B region. The killifish AHRR is 51 and
49% identical to the mouse and human AHRRs, respectively, in the
N-terminal half of the protein containing the bHLH-PAS-A/B regions,
whereas it shares 38 and 37% identity with killifish AHR1 and AHR2,
respectively, in this region (Fig. 2).
Thus, killifish AHRR is distinct from AHR1 and AHR2 and likely
represents an ortholog of the mammalian AHRRs.
Phylogenetic analysis of AHRR and AHR amino acid sequences indicates
that AHRRs from killifish, mouse, and human form a clade that is
distinct from the previously identified AHR1 and AHR2 clades (17) but
still within the larger AHR family, which also includes the
invertebrate AHR homologs from Drosophila melanogaster and
Caenorhabditis elegans (Fig.
3). The topology of the phylogenetic trees remains the same when the PAS-B domain is excluded from the
analysis, demonstrating that the classification is not solely driven by
the divergence in this region (data not shown). In addition, the
clustering of the AHRRs with vertebrate and invertebrate AHRs is
retained when sequences of other bHLH-PAS proteins are included in the
analysis (data not shown). These analyses demonstrate that the AHRR is
a third member of the vertebrate AHR family that is found in both
mammals and fish, and is distinct from AHR/AHR1 and AHR2.
AHRRs from Mammals and Fish Lack the Ability to Bind Traditional
AHR Ligands--
The relatively high degree of sequence identity
between AHRR and AHR proteins prompted us to examine the ability of
fish and mammalian AHRRs to bind typical AHR ligands. Killifish AHRR,
AHR1, and AHR2 proteins were expressed by in vitro coupled
transcription and translation (TnT), and the integrity and efficiency
of synthesis were verified by SDS-PAGE of
[35S]methionine-labeled TnT products (Fig.
4A). Unlabeled TnT reactions were incubated with [3H]TCDD (8 nM), and
specific binding was determined by a sucrose gradient velocity
sedimentation assay. As shown earlier (17), killifish AHR1 and AHR2
exhibited specific [3H]TCDD binding, which was displaced
by a 100-fold excess of unlabeled ligand (Fig. 4B). In
contrast, no specific [3H]TCDD binding was detected with
the killifish AHRR. To determine whether AHRR is capable of binding a
non-halogenated AHR ligand, in vitro expressed proteins were
incubated with [3H]BNF (10 nM). As observed
for [3H]TCDD, AHR1 and AHR2 exhibited specific binding of
[3H]BNF, whereas no specific binding of this compound was
observed with AHRR (Fig. 4C).
To determine whether the lack of binding to AHR ligands is a property
shared by fish and mammalian AHRRs, we evaluated the specific binding
of [3H]TCDD and [3H]BNF to AHRs and AHRRs
from mouse and human. As we observed for Fundulus, neither
human nor mouse AHRR was capable of binding [3H]TCDD or
[3H]BNF, whereas both human and mouse AHRs exhibited high
affinity, specific binding of these ligands (Fig.
5). Together, these data reveal that the
inability to bind planar aromatic hydrocarbons distinguishes AHRR from
the vertebrate AHRs (AHR/AHR1 and AHR2).
Repression of AHR Transactivation Function by Killifish
AHRR--
Based on the reported inhibitory effect of mouse AHRR on the
transactivation function of mouse AHR (22), we first determined whether
killifish AHRR has a similar effect on the mouse AHR. Expression
constructs for mouse AHR, human ARNT, and a luciferase reporter gene
under control of AHREs (pGudLuc6.1) were transiently expressed in COS-7
cells. Luciferase expression was induced in cells treated with TCDD (10 nM) as compared with control cells treated with
Me2SO (Fig. 6A,
lane 1). Cotransfection of either the mouse AHRR construct
or the killifish AHRR construct abolished both basal and TCDD-induced
expression of luciferase (Fig. 6A, lanes 2 and
3). By using the same reporter system, we evaluated the
ability of killifish AHRR to affect transcriptional activation mediated
by killifish AHR1 or AHR2. Each killifish AHR activated transcription
of the luciferase reporter in conjunction with killifish ARNT2 (Fig.
6B, lanes 5 and 9); TCDD treatment
up-regulated the reporter ~2.5-fold by AHR1 and 4-fold by AHR2.
Cotransfection of increasing amounts of killifish AHRR with killifish
AHR1 or AHR2 resulted in an AHRR concentration-dependent
decrease in luciferase expression, which was reduced to background
levels when 50 ng of AHRR was cotransfected (Fig. 6B,
lanes 8 and 12). Luciferase expression was AHR-
and ARNT-dependent, and no expression above background was
observed with killifish AHRR and ARNT2 in the absence of AHR. Thus,
killifish AHRR was not itself transcriptionally active, but it was able
to inhibit the transactivation function of both AHR1 and AHR2, as well
as that of the mouse AHR.
Induction of AHRR mRNA by TCDD and PCBs--
To assess the
tissue-specific expression of the killifish AHRR and its inducibility
by AHR agonists, we measured AHRR transcripts in samples of RNA
prepared for a previous study in which the inducibility of killifish
AHR1, AHR2, and CYP1A mRNA expression was measured (28). As
assessed by semi-quantitative RT-PCR, AHRR mRNA was expressed in a
variety of tissues from adult killifish (Fig.
7). Exposure to TCDD increased the
expression of AHRR, most noticeably in spleen, heart, and gut. When
killifish were treated with a mixture of PCBs, AHRR expression was
elevated mainly in liver and heart. These results demonstrate that
killifish AHRR, like CYP1A (28), is inducible by halogenated aromatic
hydrocarbons, including the potent AHR agonist TCDD.
Analysis of the F. heteroclitus AHRR Promoter--
To investigate
the mechanisms underlying the induction of AHRR by TCDD, we cloned and
sequenced the promoter region of killifish AHRR via a
genome-walking approach. Alignment of the 2358-bp promoter fragment
with the previously obtained 5'-RACE product revealed an intron of 387 bp within the 5'-upstream sequence, indicating that the first exon is
non-coding (Fig. 8A), as
reported for the murine AHRR gene (25). Scanning of the
promoter sequence for possible transcriptional regulatory elements
revealed that the killifish AHRR gene appears to have a
TATA-less promoter. Three AHRE core consensus sequences (GCGTG) are
present at positions +2,
In light of the three putative AHREs in the killifish AHRR
promoter, we tested the ability of ligand-activated killifish AHR1 and
AHR2 to regulate expression of a reporter gene under the control of
this sequence. The entire 2358-bp promoter fragment was fused to the
luciferase gene of pGL3-Basic to generate a reporter construct, pGL-RR.
COS-7 cells were transfected with pGL-RR and killifish ARNT2 together
with either killifish AHR1 or AHR2. Luciferase expression was
up-regulated in an AHR-dependent manner when the cells were
treated with TCDD (Fig. 8B). Both AHR1 and AHR2 supported TCDD-dependent induction of luciferase expression from
pGL-RR, although AHR2 (5.2-fold induction) appeared to be more
efficient at activating transcription through this promoter than AHR1
(1.8-fold induction). Cotransfection of killifish AHRR eliminated the
TCDD-dependent up-regulation of pGL-RR reporter activity
mediated by either killifish AHR1 or AHR2, demonstrating that AHRR is
able to repress its own promoter. Together, these results show that the
killifish AHRR gene contains a TCDD-inducible promoter that
can be activated by either AHR1 or AHR2 and can be repressed by its own
gene product.
AHRR Expression in a Dioxin-resistant Population of F. heteroclitus--
We have been investigating the molecular basis of
dioxin resistance that has evolved in a population of killifish
inhabiting a PCB-contaminated site, New Bedford Harbor, MA (28, 29,
39). Fish from New Bedford Harbor express low levels of CYP1A, despite having high tissue concentrations of PCBs, and experimental treatment of these fish with TCDD or other AHR agonists fails to induce CYP1A
expression (29). To test the hypothesis that an alteration in AHRR
expression contributes to the resistant phenotype, we compared
tissue-specific AHRR mRNA expression in adult, dioxin-sensitive fish from a reference site (Scorton Creek) to that of adult,
dioxin-resistant fish from the polluted site (New Bedford Harbor).
Using semi-quantitative RT-PCR, we found no appreciable differences
between populations in the amounts or pattern of AHRR mRNA
expression (Fig. 9). Thus, despite the
inducibility of AHRR by experimental exposure of reference site fish to
TCDD or PCBs (Fig. 7), this gene is not induced or otherwise
overexpressed in fish genetically selected for resistance to AHR
agonists following chronic environmental exposure to high concentrations of PCBs.
The AHR is a key transcriptional regulatory protein involved in
the altered gene expression and toxicity that results from exposure of
vertebrate animals to chlorinated dioxins, PCBs, polynuclear aromatic
hydrocarbons, and certain other classes of compounds (40-44). The AHR
also possesses physiological functions that are independent of
exogenous chemical exposure (5-7). Determining how the AHR signaling
pathway is regulated is necessary for understanding both of these roles
as well as for understanding the mechanisms underlying differences
among individuals, populations, or species in the response to AHR
agonists. Regulation of the AHR pathway occurs through a variety of
mechanisms, including ligand binding (45), modulation of AHR expression
and degradation (46-48), post-translational modification (37, 49),
protein-protein interactions (50-56), and transcriptional repression
(57, 58). Mechanisms of transcriptional repression may involve
competition for cofactors (59-61), binding to negative regulatory
elements (57, 62, 63), or interference with the AHRE binding of the
AHR-ARNT complex (58, 64, 65). The recent cloning and characterization
of the AHRR in mice (22) identified a novel autoregulatory loop
involving the bHLH-PAS proteins AHR, ARNT, and AHRR. The data presented
here demonstrate that this regulatory mechanism is evolutionarily
conserved and that it can also involve a fourth bHLH-PAS protein, AHR2.
We show for the first time that mammalian and fish AHRRs are unable to bind the AHR ligands TCDD and BNF. We demonstrate also that AHRR expression is inducible by halogenated AHR agonists such as TCDD and
PCBs and that AHRR is able to repress transcription induced via its own promoter.
Interactions among AHRR, AHR1, and AHR2--
Fujii-Kuriyama and
colleagues (22) showed that the mouse AHRR is capable of forming a
complex with ARNT and interacting with AHREs to inhibit AHR-mediated
transcription of a reporter gene, thus defining AHRR as a repressor of
AHR function. The results presented here demonstrate that the fish
(F. heteroclitus) ortholog of the murine AHRR also is able
to repress the function of the mouse AHR, demonstrating conservation in
the function of the AHRR over more than 400 million years since the
divergence of fish and mammalian lineages. In addition to its effect on
the function of the mouse AHR, the killifish AHRR acts as a repressor
of AHR1 (the fish ortholog of the mammalian AHR) as well as AHR2, which is possibly a fish-specific AHR form (17).
Other elements of the AHRR-AHR autoregulatory loop also are conserved.
Mimura et al. (22) reported induction of mouse AHRR mRNA
in vivo by the polynuclear aromatic hydrocarbon 3MC, a known AHR agonist. We have extended those results by showing that AHRR, like
CYP1A, is inducible also by halogenated AHR ligands, including TCDD and
a PCB mixture. Consistent with this, both fish (Fig. 8) and mouse (22)
AHRR promoters contain consensus AHRE sequences that
function in transient transfection assays to mediate
AHR-dependent induction of reporter gene expression in
response to TCDD (this study) or 3MC (22). In the present study, both
AHR1 and AHR2 were capable of supporting inducible transcription from
the AHRR promoter (Fig. 6). In addition, killifish AHRR was
shown to repress either AHR1- or AHR2-dependent
transcription from its own promoter (Fig. 8) in addition to its
repression of promoters regulated by enhancer elements from the murine
Cyp1a1 gene (Fig. 6 and Ref. 22). This finding suggests that
the autoregulatory loop involving AHRR and AHRs likely includes a
variety of AHR-regulated genes that are first induced via the AHR and
then subsequently repressed by the induced AHRR.
AHRR Function Is Ligand-independent--
Previous results (22)
with the mouse AHRR had suggested that the ability of this protein to
interact with ARNT and bind AHRE sequences was independent of ligand,
but ligand binding had not been assessed directly. The data presented
here reveal that neither the mouse, human, nor killifish AHRR is
capable of specific, high affinity binding of [3H]TCDD or
[3H]BNF. This finding, although not previously
demonstrated, is consistent with the poor sequence conservation between
AHRs and AHRRs in the PAS-B domain, which forms part of the
ligand-binding domain of AHRs (13, 66-68). Thus, the function of AHRR
proteins appears to be ligand-independent, unlike their expression,
which is regulated by ligands acting through binding to AHRs.
AHRR: Role in Evolved Dioxin Resistance--
F.
heteroclitus is emerging as a valuable model vertebrate for
studying the evolution and adaptive significance of AHR signaling pathways. This species is sensitive to dioxins (69) and possesses an
inducible CYP1A1 (70), indicating the existence of a functional AHR
signaling system. However, following multigenerational exposure to high
levels of dioxins and PCBs, killifish develop heritable resistance to
AHR agonists (29, 39, 71, 72). One hypothesis concerning the mechanism
of resistance involves the increased expression of a repressor protein
that is able to prevent AHR-dependent alterations in gene
expression (29, 73). Analysis of a set of tissue RNAs from adult,
dioxin-sensitive and dioxin-resistant fish showed no evidence for
up-regulation of AHRR in the resistant fish (Fig. 9). This suggests
that altered transcriptional regulation of AHRR is not associated with
the resistance mechanism in adult fish. However, the possible role of
such a mechanism in the resistance seen in killifish embryos and larvae
(39) is not addressed by this experiment. Similarly, the possibility of
mechanisms involving altered functional properties or
post-transcriptional regulation of AHRR specific to dioxin-resistant
fish remains to be evaluated.
AHRR, AHR1, and AHR2 Comprise Three Members of the Vertebrate AHR
Gene Family--
The identification and characterization of an AHRR in
a teleost fish illuminates not only the conserved nature of this gene but the evolutionary history of the AHR family as well. F. heteroclitus is the first species in which three AHR-related genes
have been found. We have also identified an AHRR homolog in the
zebrafish (Danio
rerio),5 a species that
also possesses an AHR1 (18) and AHR2 (20). The zebrafish
AHRR gene maps6 to
linkage group 24, which contains regions of conserved synteny (74, 75)
with human chromosome 5, the location of the human AHRR gene
(25). Together with the data presented here, this provides strong
evidence for orthology between the fish and mammalian AHRRs.
Phylogenetic analysis of AHR and AHRR amino acid sequences from mammals
and fish demonstrates that these genes segregate into three groups
(clades): AHR/AHR1, AHR2, and AHRR (Fig. 3). The AHR2 clade is known so
far only from fish, and we have suggested (17, 76) that AHR2 was lost
at some point in the lineage leading to mammals. Importantly, the
present results show definitively that AHRR and
AHR2 are distinct genes, a conclusion that is also supported
by the mapping of zebrafish AHR1, AHR2, and
AHRR to separate linkage groups (18, 76).6 In
phylogenetic analyses, AHR/AHR1, AHR2, and AHRR all fall within a
larger group that also includes the single AHR homolog identified in
several invertebrate species (10, 77-79); we refer to this larger
group as the "AHR family" within the bHLH-PAS protein superfamily (17, 79). The topology of the phylogenetic trees strongly suggests that
the three vertebrate members of the AHR family arose and diverged
following two duplications of an ancestral AHR gene, which
is represented today by a single AHR-like gene in invertebrate animals.
The trees, combined with the ligand-binding data presented here (Figs.
4 and 5) and elsewhere (77, 79), further imply that the ability to bind
planar aromatic compounds first evolved in the vertebrate lineage and
after the gene duplication that resulted in the ancestral
AHR and AHRR genes. Thus, AHR1 and AHR2, which
arose from a second gene duplication subsequent to the AHR/AHRR split,
are both capable of specific, high affinity binding of TCDD (1, 17,
19), whereas neither AHRR (this study) nor the invertebrate AHR
homologs (77, 79) possess this property.
In summary, the AHRR defines a third member of the AHR family in
vertebrate animals and is part of an evolutionarily conserved autoregulatory loop that involves AHR1 and AHR2 in addition to ARNT or
ARNT2. AHRR does not itself bind aromatic hydrocarbons, but its
expression can be induced by halogenated and nonhalogenated aromatic
hydrocarbons acting through an AHR1- or AHR2-dependent mechanism. AHRR protein is capable of repressing AHRE-containing promoters, including its own. Further characterization of AHRR function
in fish and mammals may contribute to an understanding of mechanisms
responsible for differences among species, populations, individuals,
and cell types in the response to aromatic hydrocarbon exposure.
-naphthoflavone. In transient transfection
experiments using a luciferase reporter gene under control of AHR
response elements, killifish AHRR inhibited the
TCDD-dependent transactivation function of both AHR1 and
AHR2. AHRR mRNA is widely expressed in killifish tissues and is
inducible by TCDD or polychlorinated biphenyls, but its expression is
not altered in a population of fish exhibiting genetic resistance to
these compounds. The F. heteroclitus AHRR promoter contains
three putative AHR response elements. Both AHR1 and AHR2 activated
transcription of luciferase driven by the AHRR promoter, and AHRR could
repress its own promoter. Thus, AHRR is an evolutionarily conserved,
TCDD-inducible repressor of AHR1 and AHR2 function. Phylogenetic
analysis shows that AHRR, AHR1, and AHR2
are distinct genes, members of an AHR gene family; these three
vertebrate AHR-like genes descended from a single invertebrate AHR.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
(27), and their role in evolved resistance to dioxins (28, 29). We show
here that F. heteroclitus expresses an AHRR homolog that is
able to repress the transactivation function of both AHR1 and AHR2 as
well as the murine AHR. We also show (i) that killifish AHRR expression
is inducible by TCDD and by PCBs in a variety of tissues in
vivo, (ii) that this occurs through AHRE sequences in its promoter
and can be mediated by either AHR1 or AHR2, and (iii) that the
killifish AHRR is able to repress the function of its own promoter.
However, AHRR expression, like that of other AHR-regulated genes such
as CYP1A1, is not induced in fish selected for
genetic resistance to TCDD. In addition, we demonstrate that neither
killifish AHRR, mouse AHRR, nor human AHRR is able to support high
affinity binding of the AHR ligands [3H]TCDD or
[3H]BNF, suggesting that the repressive function of this
protein is ligand-independent. Finally, our findings reveal that
AHRR is one of three members of the vertebrate
AHR gene family, which arose by duplication and divergence
of a single ancestral AHR gene.
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
-naphthoflavone, 19 Ci/mmol,
98% radiochemical purity) were obtained from Chemsyn
Science Laboratories (Lenexa, KS). [35S]Methionine was
purchased from Amersham Biosciences. TCDD and TCDF were obtained from
Ultra Scientific (Hope, RI). All other chemicals were from Sigma.
3 Prime, Inc., Boulder, CO).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

View larger version (38K):
[in a new window]
Fig. 1.
Nucleotide and deduced amino acid sequence of
the F. heteroclitus AHRR cDNA. Amino acid
residues are numbered on the left. The stop codon
is indicated by an asterisk. F. heteroclitus AHRR
has an open reading frame of 680 amino acids with a predicted molecular
mass of 75.2 kDa. The nucleotide sequence of the F. heteroclitus AHRR cDNA has been deposited in the
GenBankTM data base with accession number AF443441.

View larger version (67K):
[in a new window]
Fig. 2.
Alignment of AHRR and AHR amino acid
sequences. The N-terminal regions of AHRR and AHR deduced amino
acid sequences were aligned using ClustalX. Amino acids that are
identical in three or more sequences are boxed and
shaded. The bHLH region and PAS domain are indicated by
lines above the alignment. The ligand-binding domain of AHRs
(67) is in brackets. See the legend to Fig. 3 for
GenBankTM accession numbers of the sequences used. Prefixes
used: Fh, F. heteroclitus; Mm,
Mus musculus; Hs, Homo sapiens.

View larger version (20K):
[in a new window]
Fig. 3.
Phylogenetic analysis of AHRR and AHR
proteins. The phylogenetic tree was constructed using
Maximum Parsimony in PAUP*4.0b8 as described under "Materials and
Methods." The sequences used corresponded to the N-terminal halves of
the proteins, excluding positions with gaps (200 informative
characters). Because of the low sequence identity among AHRs and AHRRs
within the distal half of the protein and the resulting uncertainties
in the alignments in this region, comparisons of the N-terminal halves
of the proteins are most accurate. A single most parsimonious tree was
found using an exhaustive search; it composed 949 steps.
AHR1, AHR2, and AHRR clades are
indicated. A similar topology was obtained using the distance
criterion; the only difference was that in the distance tree, zebrafish
AHR1 was basal to a group containing F. heteroclitus AHR1
and the mammalian AHRs, all still within the AHR1 clade.
GenBankTM accession numbers and amino acid (aa) residues of
the sequences used are as follows: killifish AHRR (AF443441; aa
1-398), mouse AHRR (AB015140; aa 1-390), human AHRR (AB033060; aa
1-421), human AHR (L19872; aa 1-414), mouse AHR (M94623; aa 1-408),
killifish AHR1 (AF024591; aa 1-409), killifish AHR2 (U29679; aa
1-406), zebrafish AHR1 (AF258854; aa 1-419), zebrafish AHR2
(AF063446; aa 1-419), D. melanogaster AHR (AF050630; aa
1-398), and C. elegans AHR (AF039570; aa 1-413).

View larger version (36K):
[in a new window]
Fig. 4.
Velocity sedimentation analysis of ligand
binding by the killifish AHRR in comparison to AHR1 and AHR2.
A, in vitro transcription/translation of
killifish AHR1, killifish AHR2, and killifish AHRR. pcDNA-FhAHR1*1,
pcDNA-FhAHR2, and pcDNA-FhAHRR constructs were expressed in TnT
T7 Quick-coupled Reticulocyte Lysate Systems to synthesize
[35S]methionine-labeled proteins. The TnT reactions were
electrophoresed on the same SDS-polyacrylamide gel, followed by
fluorography. B, binding of [3H]TCDD to
killifish AHR1, AHR2, and AHRR. For each protein, two identical TnT
reactions (100 µl total) were combined, diluted 1:1 with MEEDMG
buffer, split into two 100-µl aliquots, and incubated overnight at
4 °C with [3H]TCDD (8 nM) (filled
squares) or [3H]TCDD (8 nM) + TCDF (800 nM) (open squares) and fractionated on 10-30%
sucrose gradients. The binding of [3H]TCDD to
unprogrammed lysate (UPL) was also assessed, as an
independent measure of nonspecific binding (open circles).
C, binding of [3H]BNF to killifish AHR1, AHR2,
and AHRR. For each protein, two identical TnT reactions (100 µl
total) were combined, diluted 1:1 with MEEDMG buffer, split into two
100-µl aliquots, and incubated overnight at 4 °C with
[3H]BNF (10 nM) (filled squares)
or [3H]BNF (10 nM) + unlabeled BNF (1 µM) (open squares) and fractionated on
10-30% sucrose gradients. The binding of [3H]BNF to
unprogrammed lysate was also assessed as an independent measure of
nonspecific binding (open circles). Radioligand
concentrations were verified by sampling each tube for total counts.
The sedimentation markers [14C]ovalbumin (3.6 S) and
[14C]catalase (11.3 S) eluted at fractions 3-4 and
15-16, respectively. Specific binding is the difference between total
binding (radioligand only) and nonspecific binding (radioligand plus
100-fold excess cold ligand, or radioligand binding to UPL). Results
shown are representative of two independent experiments that gave
similar results.

View larger version (25K):
[in a new window]
Fig. 5.
Velocity sedimentation analysis of ligand
binding by human and mouse AHRRs in comparison to human and mouse AHRs.
A, in vitro transcription/translation of mouse
AHR (mAHR), mouse AHRR (mAHRR), human AHR
(hAHR), and human AHRR (hAHRR). pSportMAHR,
pcDNA-mAHRR, pSporthAHR2, and pcDNA-hAHRR constructs were
expressed in TnT T7 or SP6 Quick-coupled Reticulocyte Lysate Systems to
synthesize [35S]methionine-labeled proteins. The TnT
reactions were electrophoresed on the same SDS-polyacrylamide gel,
followed by fluorography. B, binding of
[3H]TCDD to mouse AHR, mouse AHRR, human AHR, and
human AHRR. For each protein, a single TnT reaction (50 µl) was
diluted 1:1 with MEEDMG buffer, incubated overnight at 4 °C with
[3H]TCDD (8 nM) (filled squares),
and fractionated on 10-30% sucrose gradients. The binding of
[3H]TCDD to unprogrammed lysate (UPL) was also
assessed, as a measure of nonspecific binding (open
circles). C, binding of [3H]BNF to mouse
AHR, mouse AHRR, human AHR, and human AHRR. For each protein, a single
TnT reaction (50 µl) was diluted 1:1 with MEEDMG buffer, incubated
overnight at 4 °C with [3H]BNF (10 nM)
(filled squares), and fractionated on 10-30% sucrose
gradients. The binding of [3H]BNF to unprogrammed lysate
(UPL) was also assessed, as a measure of nonspecific binding
(open circles). Radioligand concentrations were verified by
sampling each tube for total counts. The sedimentation markers
[14C]ovalbumin (3.6 S) and [14C]catalase
(11.3 S) eluted at fractions 3-4 and 15-16, respectively. Specific
binding is the difference between total binding (radioligand binding to
expressed protein) and nonspecific binding (radioligand binding to
UPL).

View larger version (14K):
[in a new window]
Fig. 6.
Inhibition of AHR-dependent
transactivation by the killifish AHRR. A, repression of
mouse AHR transactivation function. COS-7 cells were transfected with
pGudLuc6.1 and pRL-TK along with mouse AHR, human ARNT, ±AHRR
expression constructs as indicated in the figure and described under
"Materials and Methods." Cells were treated with Me2SO
(DMSO) or TCDD and luciferase activities measured after
18 h. B, inhibition of killifish AHR1- and
AHR2-dependent transactivation by killifish AHRR. COS-7
cells were transfected with pGudLuc6.1 and pRL-TK along with expression
constructs for killifish AHR1 or AHR2, killifish ARNT2, ± killifish
AHRR as indicated in the figure and described under "Materials and
Methods." Numbers for FhAHRR indicate nanograms of DNA
transfected. Cells were treated with Me2SO or TCDD and
luciferase activities measured after 18 h. Relative luciferase
units were calculated by normalizing firefly luciferase activity to the
transfection control Renilla luciferase. Each data point
represents the mean of triplicate wells and error bars
represent S.D. Results shown are representative of three independent
experiments. Prefixes used are as follows: Fh, F. heteroclitus; Mm, M. musculus;
Hs, H. sapiens.

View larger version (25K):
[in a new window]
Fig. 7.
Effect of TCDD and PCB exposure on AHRR
expression in adult killifish tissues. Fish were injected
intraperitoneally with TCDD (10 ng/g) (A) or mixed PCBs
(Aroclor 1254/1242) (200 µg total PCBs/g) (B) and held
24 h (TCDD) or 5 days (PCBs) before dissection as described
earlier (28). RT-PCR products of AHRR and actin were electrophoresed on
agarose gels and stained with ethidium bromide. The integrated
densities of AHRR bands were normalized to those of actin bands.
986, and
1177 in relation to the
transcriptional start site (as determined from the
longest 5'-RACE product), and a GC box is present at
1016 (Fig.
8A). We did not find any NF
B sites in this region, unlike
the mouse AHRR promoter (25).

View larger version (43K):
[in a new window]
Fig. 8.
Structural and functional analysis of the
F. heteroclitus AHRR promoter. A,
sequence of killifish AHRR upstream regulatory region as determined by
genome walking. Three consensus AHRE sequences are boxed,
and one GC box is underlined. The putative transcriptional
start site based on the longest 5'-RACE product is labeled as
+1. The lowercase region indicates the intron
within the 5'-upstream sequence. The translation initiation codon ATG
is in bold. The nucleotide sequence of the killifish AHRR
promoter has been deposited in the GenBankTM data base with
accession number AF443442. B, AHR-dependent
transactivation via the killifish AHRR promoter. The entire
promoter region depicted in A was ligated into the
pGL3-basic vector to drive firefly luciferase expression (construct
pGL-RR). COS-7 cells were transiently transfected with the pGL-RR and
pRL-TK along with expression constructs for killifish AHR1 or AHR2,
killifish ARNT2, ± killifish AHRR as indicated in the figure and
described under "Materials and Methods." Cells were treated with
Me2SO (DMSO) or TCDD and luciferase activities
measured after 18 h. Relative luciferase units were calculated by
normalizing firefly luciferase activity to the transfection control
Renilla luciferase. Each data point represents the mean of
triplicate wells, and error bars represent S.D. Results
shown are representative of two independent experiments. The prefix
used is Fh for F. heteroclitus.

View larger version (38K):
[in a new window]
Fig. 9.
AHRR tissue-specific expression pattern in
dioxin-sensitive and dioxin-resistant populations of F. heteroclitus. Shown are ethidium bromide-stained gels
of RT-PCR products for AHRR and actin from the indicated tissues of
adult killifish from Scorton Creek (dioxin-sensitive) or New Bedford
Harbor (dioxin-resistant). PCRs were performed under conditions in
which formation of product was linearly related to cycle number and
amount of input cDNA. The abbreviations indicate tissue source of
RNA: B, brain; Gi, gill; K, kidney;
O, ovary; S, spleen; Gu, gut;
L, liver; H, heart. Additional details concerning
these fish, including expression of AHR1, AHR2, ARNT2, and CYP1A, can
be found elsewhere (28, 29).
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
| |
ACKNOWLEDGEMENTS |
|---|
We thank Rachel Bright for assistance in preparing the RNA samples from TCDD-treated killifish and Dr. Margie Oleksiak (University of Missouri, Kansas City, MO) for the killifish genomic DNA. We also thank Dr. Susan Bello (University of Wisconsin, Madison, WI) for efforts in maintaining the killifish and Dr. Rebeka Merson for comments on the manuscript. We are grateful for the expression constructs provided by Dr. C. Bradfield (University of Wisconsin, Madison), Dr. M. Denison (University of California, Davis), Dr. Takahiro Nagase (Kazusa DNA Research Institute, Chiba, Japan), and Dr. Y. Fujii-Kuriyama (Tohoku University, Sendai, Japan). We thank Dr. Robert Tanguay for sharing the complete sequence of zebrafish AHR1 prior to publication.
| |
FOOTNOTES |
|---|
* This work was supported in part by National Institutes of Health Grants R01 ES06272 (to M. E. H.) and F32 ES05800 (to W. H. P.) and the Superfund Basic Research Program Grant P42 ES07381 at Boston University. This is contribution 10562 from the Woods Hole Oceanographic Institution.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AF443441 and AF443442.
Present address: Biology Dept., Kenyon College, Gambier, OH 43022.
§ To whom correspondence should be addressed: Biology Dept., MS 32, Woods Hole Oceanographic Institution, Woods Hole, MA 02543-1049. Tel.: 508-289-3242; Fax: 508-457-2134; E-mail: mhahn@whoi.edu.
Published, JBC Papers in Press, December 12, 2001, DOI 10.1074/jbc.M110779200
2 The binding site for the AHR-ARNT complex was originally named "xenobiotic response element" or "dioxin-response element" because of its role in mediating the response to dioxins and related xenobiotics. Recently, however, it has been shown that in some systems the AHR-ARNT complex can bind this sequence in the absence of dioxin or other xenobiotic ligand (77, 79, 80). Therefore, we use the term AHRE (aryl hydrocarbon response element or AHR response element) (81, 82), which more accurately reflects the function of this element as a binding site for the AHR-ARNT complex.
3 The nomenclature used for genes and proteins discussed in this paper is according to the guidelines of the human gene nomenclature committee (83), which specifies all capital letters and italicized for gene symbols and all capital letters and non-italicized for gene products; thus, AHR and AHRR genes encode AHR and AHRR proteins, respectively.
4 M. E. Hahn, D. G. Franks, and S. I. Karchner, manuscript in preparation.
5 B. R. Evans and M. E. Hahn, unpublished data.
6 B. R. Evans, M. Ekker, and M. E. Hahn, unpublished data.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
AHR, aryl
hydrocarbon receptor;
AHRE, aryl hydrocarbon (receptor) response
element;
AHRR, aryl hydrocarbon receptor repressor;
ARNT, aryl
hydrocarbon receptor nuclear translocator;
bHLH, basic-helix-loop-helix;
BNF,
-naphthoflavone;
CYP1A, cytochrome P450
1A;
Me2SO, dimethyl sulfoxide;
3MC, 3-methylcholanthrene;
PAS, Per-ARNT-Sim homology;
PCB, polychlorinated
biphenyl;
RT, reverse transcription;
RACE, rapid amplification of
cDNA ends;
TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin;
TCDF, 2,3,7,8-tetrachlorodibenzofuran;
aa, amino acid;
DMEM, Dulbecco's modified Eagle's medium;
UPL, unprogrammed lysate.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Poland, A.,
Glover, E.,
and Kende, A. S.
(1976)
J. Biol. Chem.
251,
4936-4946 |
| 2. | Schmidt, J. V., and Bradfield, C. A. (1996) Annu. Rev. Cell Dev. Biol. 12, 55-89[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Hankinson, O. (1995) Annu. Rev. Pharmacol. Toxicol. 35, 307-340[CrossRef][Medline] [Order article via Infotrieve] |
| 4. | Whitlock, J. P. (1999) Annu. Rev. Pharmacol. Toxicol. 39, 103-125[CrossRef][Medline] [Order article via Infotrieve] |
| 5. |
Lahvis, G. P.,
Lindell, S. L.,
Thomas, R. S.,
McCuskey, R. S.,
Murphy, C.,
Glover, E.,
Bentz, M.,
Southard, J.,
and Bradfield, C. A.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
10442-10447 |
| 6. | Ma, Q., and Whitlock, J. P. (1996) Mol. Cell. Biol. 16, 2144-2150[Abstract] |
| 7. | Weiss, C., Kolluri, S. K., Kiefer, F., and Gottlicher, M. (1996) Exp. Cell Res. 226, 154-163[CrossRef][Medline] [Order article via Infotrieve] |
| 8. |
Crews, S. T.
(1998)
Genes Dev.
12,
607-620 |
| 9. | Gu, Y.-Z., Hogenesch, J. B., and Bradfield, C. A. (2000) Annu. Rev. Pharmacol. Toxicol. 40, 519-561[CrossRef][Medline] [Order article via Infotrieve] |
| 10. |
Hahn, M. E.,
Karchner, S. I.,
Shapiro, M. A.,
and Perera, S. A.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
13743-13748 |
| 11. | Hahn, M. E. (1998) Comp. Biochem. Physiol. C Comp. Pharmacol. 121, 23-53 |
| 12. | Ema, M., Sogawa, K., Watanabe, N., Chujoh, Y., Matsushita, N., Gotoh, O., Funae, Y., and Fujii-Kuriyama, Y. (1992) Biochem. Biophys. Res. Commun. 184, 246-253[CrossRef][Medline] [Order article via Infotrieve] |
| 13. |
Burbach, K. M.,
Poland, A.,
and Bradfield, C. A.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
8185-8189 |
| 14. | Dolwick, K. M., Schmidt, J. V., Carver, L. A., Swanson, H. I., and Bradfield, C. A. (1993) Mol. Pharmacol. 44, 911-917[Abstract] |
| 15. | Walker, M. K., Heid, S. E., Smith, S. M., and Swanson, H. I. (2000) Comp. Biochem. Physiol. C Comp. Pharmacol. 126, 305-319 |
| 16. | Karchner, S. I., Kennedy, S. W., Trudeau, S., and Hahn, M. E. (2000) Mar. Environ. Res. 50, 51-56[CrossRef][Medline] [Order article via Infotrieve] |
| 17. |
Karchner, S. I.,
Powell, W. H.,
and Hahn, M. E.
(1999)
J. Biol. Chem.
274,
33814-33824 |
| 18. | Tanguay, R. L., Andreasen, E., Hahn, M. E., Heideman, W., and Peterson, R. E. (2001) Toxicol. Sci. 60 (Supplement 1), 67-68 (Abstr. 326) |
| 19. |
Abnet, C. C.,
Tanguay, R. L.,
Hahn, M. E.,
Heideman, W.,
and Peterson, R. E.
(1999)
J. Biol. Chem.
274,
15159-15166 |
| 20. | Tanguay, R. L., Abnet, C. C., Heideman, W., and Peterson, R. E. (1999) Biochim. Biophys. Acta 1444, 35-48[Medline] [Order article via Infotrieve] |
| 21. | Roy, N. K., and Wirgin, I. (1997) Arch. Biochem. Biophys. 344, 373-386[CrossRef][Medline] [Order article via Infotrieve] |
| 22. |
Mimura, J.,
Ema, M.,
Sogawa, K.,
and Fujii-Kuriyama, Y.
(1999)
Genes Dev.
13,
20-25 |
| 23. | Nagase, T., Ishikawa, K., Kikuno, R., Hirosawa, M., Nomura, N., and Ohara, O. (1999) DNA Res. 6, 337-345[Abstract] |
| 24. | Watanabe, T., Imoto, I., Kosugi, Y., Fukuda, Y., Mimura, J., Fujii, Y., Isaka, K., Takayama, M., Sato, A., and Inazawa, J. (2001) J. Hum. Genet. 46, 342-346[CrossRef][Medline] [Order article via Infotrieve] |
| 25. |
Baba, T.,
Mimura, J.,
Gradin, K.,
Kuroiwa, A.,
Watanabe, T.,
Matsuda, Y.,
Inazawa, J.,
Sogawa, K.,
and Fujii-Kuriyama, Y.
(2001)
J. Biol. Chem.
276,
33101-33110 |
| 26. | Powell, W. H., Karchner, S. I., Bright, R., and Hahn, M. E. (1999) Arch. Biochem. Biophys. 361, 156-163[CrossRef][Medline] [Order article via Infotrieve] |
| 27. | Powell, W. H., and Hahn, M. E. (2002) J. Exp. Zool., in press |
| 28. |
Powell, W. H.,
Bright, R.,
Bello, S. M.,
and Hahn, M. E.
(2000)
Toxicol. Sci.
57,
229-239 |
| 29. |
Bello, S. M.,
Franks, D. G.,
Stegeman, J. J.,
and Hahn, M. E.
(2001)
Toxicol. Sci.
60,
77-91 |
| 30. | Gasiewicz, T. A., and Neal, R. A. (1979) Toxicol. Appl. Pharmacol. 51, 329-339[CrossRef][Medline] [Order article via Infotrieve] |
| 31. |
Don, R. H.,
Cox, P. T.,
Wainwright, B. J.,
Baker, K.,
and Mattick, J. S.
(1991)
Nucleic Acids Res.
19,
4008 |
| 32. |
Thompson, J. D.,
Gibson, T. J.,
Plewniak, F.,
Jeanmougin, F.,
and Higgins, D. G.
(1997)
Nucleic Acids Res.
25,
4876-4882 |
| 33. | Swofford, D. L. (1998) PAUP*. Phylogenetic Analysis Using Parsimony (*and Other Methods), version 4, Sinauer Associates, Inc., Sunderland, MA |
| 34. | Wirgin, I., D'Amore, M., Grunwald, C., Goldman, A., and Garte, S. J. (1990) Biochem. Genet. 28, 459-475[CrossRef][Medline] [Order article via Infotrieve] |
| 35. |
Hoffman, E. C.,
Reyes, H.,
Chu, F.-F.,
Sander, F.,
Conley, L. H.,
Brooks, B. A.,
and Hankinson, O.
(1991)
Science
252,
954-958 |
| 36. | Garrison, P. M., Tullis, K., Aarts, J. M. M. J. G., Brouwer, A., Giesy, J. P., and Denison, M. S. (1996) Fundam. Appl. Toxicol. 30, 194-203[CrossRef][Medline] [Order article via Infotrieve] |
| 37. |
Long, W. P.,
Praygrant, M.,
Tsai, J. C.,
and Perdew, G. H.
(1998)
Mol. Pharmacol.
53,
691-700 |
| 38. |
Jensen, B. A.,
and Hahn, M. E.
(2001)
Toxicol. Sci.
64,
41-56 |
| 39. | Nacci, D., Coiro, L., Champlin, D., Jayaraman, S., McKinney, R., Gleason, T., Munns, W. R., Jr., Specker, J. L., and Cooper, K. (1999) Mar. Biol. (New York) 134, 9-17[CrossRef] |
| 40. |
Fernandez-Salguero, P.,
Pineau, T.,
Hilbert, D. M.,
McPhail, T.,
Lee, S. S. T.,
Kimura, S.,
Nebert, D. W.,
Rudikoff, S.,
Ward, J. M.,
and Gonzalez, F. J.
(1995)
Science
268,
722-726 |
| 41. | Fernandez-Salguero, P., Hilbert, D. M., Rudikoff, S., Ward, J. M., and Gonzalez, F. J. (1996) Toxicol. Appl. Pharmacol. 140, 173-179[CrossRef][Medline] [Order article via Infotrieve] |
| 42. |
Schmidt, J. V., Su, G. H.-T.,
Reddy, J. K.,
Simon, M. C.,
and Bradfield, C. A.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
6731-6736 |
| 43. |
Shimizu, Y.,
Nakatsuru, Y.,
Ichinose, M.,
Takahashi, Y.,
Kume, H.,
Mimura, J.,
Fujii-Kuriyama, Y.,
and Ishikawa, T.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
779-782 |
| 44. |
Peters, J. M.,
Narotsky, M. G.,
Elizondo, G.,
Fernandez-Salguero, P. M.,
Gonzalez, F. J.,
and Abbott, B. D.
(1999)
Toxicol. Sci.
47,
86-92 |
| 45. |
Lees, M. J.,
and Whitelaw, M. L.
(1999)
Mol. Cell. Biol.
19,
5811-5822 |
| 46. |
Vaziri, C.,
Schneider, A.,
Sherr, D. H.,
and Faller, D. V.
(1996)
J. Biol. Chem.
271,
25921-25927 |
| 47. |
Davarinos, N. A.,
and Pollenz, R. S.
(1999)
J. Biol. Chem.
274,
28708-28715 |
| 48. |
Ma, Q.,
and Baldwin, K. T.
(2000)
J. Biol. Chem.
275,
8432-8438 |
| 49. |
Carrier, F.,
Owens, R. A.,
Nebert, D. W.,
and Puga, A.
(1992)
Mol. Cell. Biol.
12,
1856-1863 |
| 50. |
Reyes, H.,
Reisz-Porszasz, S.,
and Hankinson, O.
(1992)
Science
256,
1193-1195 |
| 51. |
LaPres, J. J.,
Glover, E.,
Dunham, E. E.,
Bunger, M. K.,
and Bradfield, C. A.
(2000)
J. Biol. Chem.
275,
6153-6159 |
| 52. | Meyer, B. K., and Perdew, G. H. (1999) Biochemistry 38, 8907-8917[CrossRef][Medline] [Order article via Infotrieve] |
| 53. |
Ma, Q.,
and Whitlock, J. P.
(1997)
J. Biol. Chem.
272,
8878-8884 |
| 54. |
Carver, L. A.,
Jackiw, V.,
and Bradfield, C. A.
(1994)
J. Biol. Chem.
269,
30109-30112 |
| 55. |
Whitelaw, M. L.,
McGuire, J.,
Picard, D.,
Gustafsson, J.-A.,
and Poellinger, L.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
4437-4441 |
| 56. |
Kumar, M. B.,
Tarpey, R. W.,
and Perdew, G. H.
(1999)
J. Biol. Chem.
274,
22155-22164 |
| 57. | Boucher, P. D., Piechocki, M. P., and Hines, R. N. (1995) Mol. Cell. Biol. 15, 5144-5151[Abstract] |